Please assess the completion status of the following clinical trial:

Trial Title: Effect of Perioperative Intravenous Lidocaine on Opioid Consumption and Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernioplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male patients with American Society of Anaesthesiologists physical status (ASA PS) I and II of age 18 to 65 years~* Patients undergoing laparoscopic totally extraperitoneal repair for unilateral/bilateral inguinal hernia.~Exclusion Criteria:~* Refusal to give consent.~* ASA physical status III or more.~* Inability to comprehend pain assessment score or severe mental impairment~* Patient who weighed \< 40 kg or \>100 kg~* Severe underlying cardiac rhythm disorder~* Renal or hepatic disease~* Allergic to local anaesthetics~* Epilepsy~* Patients on regular analgesics or anti-arrhythmic drugs

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): Lignocaine group (Group A) will receive an intravenous (IV) bolus 1.5 mg/kg at induction followed by continuous infusion of 2 mg/kg/hr until the tracheal extubation.
- Normal saline (Type: PLACEBO_COMPARATOR): Normal saline group (Group B) will receive an intravenous normal saline bolus at induction followed by continuous infusion of normal saline until the tracheal extubation

Based on this trial design, predict the completion outcome and termination type (if applicable).